Format
Sort by
Items per page

Send to

Choose Destination

Best matches for metformin and cancer:

Metformin in cancer treatment and prevention. Morales DR et al. Annu Rev Med. (2015)

Metformin and cancer. Rizos CV et al. Eur J Pharmacol. (2013)

Metformin and prostate cancer stem cells: a novel therapeutic target. Mayer MJ et al. Prostate Cancer Prostatic Dis. (2015)

Search results

Items: 1 to 20 of 3984

1.

Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1.

Cha JH, Yang WH, Xia W, Wei Y, Chan LC, Lim SO, Li CW, Kim T, Chang SS, Lee HH, Hsu JL, Wang HL, Kuo CW, Chang WC, Hadad S, Purdie CA, McCoy AM, Cai S, Tu Y, Litton JK, Mittendorf EA, Moulder SL, Symmans WF, Thompson AM, Piwnica-Worms H, Chen CH, Khoo KH, Hung MC.

Mol Cell. 2018 Aug 16;71(4):606-620.e7. doi: 10.1016/j.molcel.2018.07.030.

PMID:
30118680
2.

Inhibitory Effect of Anoectochilus formosanus Extract on Hyperglycemia-Related PD-L1 Expression and Cancer Proliferation.

Ho Y, Chen YF, Wang LH, Hsu KY, Chin YT, Yang YSH, Wang SH, Chen YR, Shih YJ, Liu LF, Wang K, Whang-Peng J, Tang HY, Lin HY, Liu HL, Lin SJ.

Front Pharmacol. 2018 Aug 2;9:807. doi: 10.3389/fphar.2018.00807. eCollection 2018.

3.

Survival impact and toxicity of metformin in head and neck cancer: An analysis of the SEER-Medicare dataset.

Stokes WA, Eguchi M, Amini A, Hararah MK, Ding D, McDermott JD, Bradley CJ, Karam SD.

Oral Oncol. 2018 Sep;84:12-19. doi: 10.1016/j.oraloncology.2018.06.022. Epub 2018 Jun 30.

PMID:
30115470
4.

Inhalational supplementation of metformin butyrate: A strategy for prevention and cure of various pulmonary disorders.

Maniar K, Singh V, Moideen A, Bhattacharyya R, Chakrabarti A, Banerjee D.

Biomed Pharmacother. 2018 Aug 13;107:495-506. doi: 10.1016/j.biopha.2018.08.021. [Epub ahead of print] Review.

PMID:
30114633
5.

Targeting colorectal cancer cell metabolism through development of cisplatin and metformin nano-cubosomes.

Saber MM, Al-Mahallawi AM, Nassar NN, Stork B, Shouman SA.

BMC Cancer. 2018 Aug 15;18(1):822. doi: 10.1186/s12885-018-4727-5.

6.

Molecular Mechanisms of Metformin for Diabetes and Cancer Treatment.

Li M, Li X, Zhang H, Lu Y.

Front Physiol. 2018 Jul 31;9:1039. doi: 10.3389/fphys.2018.01039. eCollection 2018. Review.

7.

The benefits of adding metformin to tamoxifen to protect the endometrium- a randomized placebo-controlled trial.

Davis SR, Robinson PJ, Jane F, White S, Brown KA, Piessens S, Edwards A, McNeilage J, Woinarski J, Chipman M, Bell RJ.

Clin Endocrinol (Oxf). 2018 Aug 14. doi: 10.1111/cen.13830. [Epub ahead of print]

PMID:
30107043
8.

Metformin Discontinuation prior to FDG PET/CT: A Randomized Controlled Study to Compare 24- and 48-hour Bowel Activity.

Hamidizadeh R, Eftekhari A, Wiley EA, Wilson D, Alden T, Bénard F.

Radiology. 2018 Aug 14:180078. doi: 10.1148/radiol.2018180078. [Epub ahead of print]

PMID:
30106348
9.

To Hold or Not to Hold Metformin for FDG PET Scans: That Is the Question.

Cho SY.

Radiology. 2018 Aug 14:181566. doi: 10.1148/radiol.2018181566. [Epub ahead of print] No abstract available.

PMID:
30106340
10.

Metformin reverses stem cell‑like HepG2 sphere formation and resistance to sorafenib by attenuating epithelial‑mesenchymal transformation.

Feng Y, Guo X, Huang X, Wu M, Li X, Wu S, Luo X.

Mol Med Rep. 2018 Aug 3. doi: 10.3892/mmr.2018.9348. [Epub ahead of print]

PMID:
30106125
11.

Metformin induces miR-378 to downregulate the CDK1, leading to suppression of cell proliferation in hepatocellular carcinoma.

Zhou J, Han S, Qian W, Gu Y, Li X, Yang K.

Onco Targets Ther. 2018 Jul 31;11:4451-4459. doi: 10.2147/OTT.S167614. eCollection 2018.

12.

Synchronized Ratiometric Codelivery of Metformin and Topotecan through Engineered Nanocarrier Facilitates In Vivo Synergistic Precision Levels at Tumor Site.

Banala VT, Sharma S, Barnwal P, Urandur S, Shukla RP, Ahmad N, Mittapelly N, Pandey G, Dwivedi M, Kalleti N, Mitra K, Rath SK, Trivedi R, Mishra PR.

Adv Healthc Mater. 2018 Aug 13:e1800300. doi: 10.1002/adhm.201800300. [Epub ahead of print]

PMID:
30102470
13.

The Impact of Serum Glucose, Anti-Diabetic Agents, and Statin Usage in Non-small Cell Lung Cancer Patients Treated With Definitive Chemoradiation.

Iarrobino NA, Gill BS, Bernard M, Klement RJ, Werner-Wasik M, Champ CE.

Front Oncol. 2018 Jul 27;8:281. doi: 10.3389/fonc.2018.00281. eCollection 2018.

14.

Evaluation of Metformin on Cognitive Improvement in Patients With Non-dementia Vascular Cognitive Impairment and Abnormal Glucose Metabolism.

Lin Y, Wang K, Ma C, Wang X, Gong Z, Zhang R, Zang D, Cheng Y.

Front Aging Neurosci. 2018 Jul 27;10:227. doi: 10.3389/fnagi.2018.00227. eCollection 2018.

15.

Use of metformin and survival of patients with high-grade glioma.

Seliger C, Luber C, Gerken M, Schaertl J, Proescholdt M, Riemenschneider MJ, Meier CR, Bogdahn U, Leitzmann MF, Klinkhammer-Schalke M, Hau P.

Int J Cancer. 2018 Aug 9. doi: 10.1002/ijc.31783. [Epub ahead of print]

PMID:
30091464
16.
17.
18.

Mitochondria-targeted drugs stimulate mitophagy and abrogate colon cancer cell proliferation.

Boyle KA, Van Wickle J, Hill RB, Marchese A, Kalyanaraman B, Dwinell MB.

J Biol Chem. 2018 Aug 7. pii: jbc.RA117.001469. doi: 10.1074/jbc.RA117.001469. [Epub ahead of print]

19.

Validation of the Survival Benefits of Metformin in Middle Eastern Patients With Type II Diabetes Mellitus and Colorectal Cancer.

Al Omari A, Abdelkhaleq H, Al-Hussaini M, Turfa R, Awad N, Hassan MM, Alfaqih MA, Garrett CR.

J Glob Oncol. 2018 Jul;(4):1-10. doi: 10.1200/JGO.18.00018.

PMID:
30084749
20.

Chinese herbal products and the reduction of risk of breast cancer among females with type 2 diabetes in Taiwan: A case-control study.

Wu CT, Tsai YT, Lin JG, Fu SL, Lai JN.

Medicine (Baltimore). 2018 Aug;97(31):e11600. doi: 10.1097/MD.0000000000011600.

Supplemental Content

Loading ...
Support Center